Study Group: Pediatricians in Private Practice (US)(?)
Council Members in this Study Group: 336
Request a survey with this Study Group
Leading Experts in this Study Group
Michael Blaiss, MDPartner
Allergy & Asthma Care
Michael S. Blaiss, MD, is a Clinical Professor of Pediatrics and Medicine at University of Tennessee Health Sciences Center and in private practice at Allergy & Asthma Care in Memphis. Dr. Blaiss’s clinical focus is on allergies and has expertise in outcomes research in allergic disorders, especially...
Allergy Specialist and Partner
Allergy & Asthma Consultants Of The Ozarks Ltd
Mark Vandewalker, MD, is an Allergy Specialist at Allergy and Asthma Consultants and he is the Medical Director at Clinical Research of the Ozarks in Missouri. Dr. Vandewalker is board-certified in Pediatric Allergy and has been practicing for almost 25 years. His areas of expertise include allergic...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Pediatricians (US) | 1665 |
| Pediatricians who Treat RSV (US) | 290 |
| Pediatricians who Treat RSV | 351 |
| Gardasil Prescribers (US) | 265 |
| Pediatric Allergist Physicians in the U.S. | 136 |
| Pediatric Allergy Physicians | 179 |
| Physicians who Treat Asthma (US) | 458 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
There is a alot of information in the media about the dangers of givng OTC cough medication to young children . Many children have ended up in the emergency room after "over-ingesting" "cold remedy products that include OTC antihistamines, decongestants and cough suppressants. Also when...
This study looked at drugs that were eventually approved by the FDA, and found that only 43% of early phase (non-"pivotal") trials were published in the medical literature. But imagine what this means for drugs that ultimately fail: if drugs that are destined for success are withholding 57% of...
There is already a bounty of data to support anti-retroviral (and other) HIV medications in post-exposure prophylaxis, be it in infants born to HIV-positive mothers; intra-partum prophylaxis to HIV-positive women in active labor; and to healthcare workers (and others) exposed to HIV from accidental...
This recent report characterizes a newly discovered anti-IgE monoclonal antibody (mAb12) which appears dramatically more potent than omalizumab (Xolair) in its ability to reduce systemic IgE levels. If further studies confirm this enhanced reduction of IgE and IgE-bearing cells, mAb12 has significant...
Or whatever the total cost of Erbitux is that is required to get you four more weeks of life. This is basically what it comes down to. Most cost-benefit analyses will justify up to $60K spent per year of life in amortized costs, but not above that. So the total costs of Erbitux...
Most Common Company Types:
- Office Based Private Practice or Clinic
- Academic Medical Center/Hospital or Clinic
- Non-Academic Community Hospital or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Owner
- Partner
- President
- Physician - Director
- Director
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

